சாரா டியான் மார்க்விஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சாரா டியான் மார்க்விஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சாரா டியான் மார்க்விஸ் Today - Breaking & Trending Today

Innovative Medicines Canada / Médicaments novateurs Canada: Innovative Medicines Canada Responds to Calls for Disclosure of Proprietary Business Information


Innovative Medicines Canada / Médicaments novateurs Canada: Innovative Medicines Canada Responds to Calls for Disclosure of Proprietary Business Information
February 19, 2021 /
Innovative Medicines Canada (IMC) issued the following statement in response to calls for the disclosure of proprietary business information related to the federal government s procurement of vaccines and medicines for COVID-19:
Canada s innovative medicines companies continue to work closely with one another and with governments at all levels in the fight against COVID-19. As part of this effort, several IMC members have entered into confidential agreements with the federal government to provide Canadians with COVID-19 medicines and vaccines.
As we have indicated before, companies entered into those agreements on the assumption that the government s legal obligations protecting their commercially sensitive and proprietary information would be honoured. If this commercially sensitive inf ....

Kostenloser Wertpapierhandel , Sarah Dion Marquis , Innovative Medicines Canada , Medicines Canada , M 233 Dicaments , சாரா டியான் மார்க்விஸ் , புதுமையானது மருந்துகள் கனடா , மருந்துகள் கனடா ,

Innovative Medicines Canada / Médicaments novateurs Canada: Innovative Medicines Canada Statement Regarding EU Export Mechanism for COVID-19 Vaccines


(1)
OTTAWA, ON / ACCESSWIRE / February 2, 2021 / Innovative Medicines Canada (IMC) issued the following statement regarding the announcement by the European Commission regarding an authorisation mechanism that may restrict or delay the export of COVID-19 vaccines to non-member states:
We understand the frustration caused by the temporary reductions in COVID-19 vaccines being delivered to European Union countries. We also appreciate the desire by governments around the world to do everything in their power to secure adequate doses of vaccines to protect their populations from the virus s spread. These are unfortunate symptoms of the epic scale of the response required to fight the virus. ....

Kostenloser Wertpapierhandel , Sarah Dion Marquis , European Union , European Commission , Innovative Medicines Canada , Medicines Canada , சாரா டியான் மார்க்விஸ் , ஐரோப்பிய தொழிற்சங்கம் , ஐரோப்பிய தரகு , புதுமையானது மருந்துகள் கனடா , மருந்துகள் கனடா ,

Innovative Medicines Canada / Médicaments novateurs Canada: New IMC Report Shows Impact of Chronic Disease and Increased Claims on Private Drug Plans


Innovative Medicines Canada / Médicaments novateurs Canada: New IMC Report Shows Impact of Chronic Disease and Increased Claims on Private Drug Plans
2016-2019 Analysis of Private Drug Claim Cost Drivers
report, released today. The report also finds that drug claim costs are rising at approximately 5% annually, less than half of the 11% that insurers have projected.
The report demonstrates that the major cost increases to private health benefit plans in Canada are a result of increased drug utilization due to the growth in chronic diseases, like diabetes, requiring access to more medications. Given the significant impact of chronic disease on private drug plan claims costs and growth, to say nothing of their social and economic costs, there is an opportunity for employers, plan providers, and other stakeholders to work together to enhance the opportunities for plan members to reduce their risk of developing chronic diseases. ....

Kostenloser Wertpapierhandel , Joe Farago , Sarah Dion Marquis , Innovative Medicines Canada , Private Drug Claim Cost Driversreport , Executive Director , Private Payers , Innovative Medicines , Medicines Canada , M 233 Dicaments , ஓஹோ ஃபராகோ , சாரா டியான் மார்க்விஸ் , புதுமையானது மருந்துகள் கனடா , நிர்வாகி இயக்குனர் , ப்ரைவேட் செலுத்துவோர் , புதுமையானது மருந்துகள் , மருந்துகள் கனடா ,

Innovative Medicines Canada / Médicaments novateurs Canada: Delaying Implementation of PMPRB's Regulations an Opportunity to Protect Patient Access to Medicines and Vaccines Says Innovative Medicines Canada


(1)
OTTAWA, ON / ACCESSWIRE / December 30, 2020 / Innovative Medicines Canada issued the following statement today in response to news from Health Canada that implementation of the Patented Medicine Prices Review Board s amended Regulations will be delayed to July 1, 2021:
We support Health Canada s decision to delay the implementation of the Patented Medicine Prices Review Board s amended Regulations until July 1, 2021. This is good news for Canadian patients concerned about the negative impact the regulations will have on their access to new medicines.
The middle of a global pandemic is not the time to implement measures that will distract from the fight against COVID-19. Additionally, and as a majority of stakeholders to the PMPRB consultation processes have consistently indicated, these changes will also have a negative impact on patients access to potentially life-saving medicines and vaccines, and on investments in Canada s vitally important life sciences sect ....

Kostenloser Wertpapierhandel , Sarah Dion Marquis , Health Canada , Innovative Medicines Canada , Patented Medicine Prices Review Board , Medicines Canada , சாரா டியான் மார்க்விஸ் , ஆரோக்கியம் கனடா , புதுமையானது மருந்துகள் கனடா , காப்புரிமை பெற்றது மருந்து ப்ரைஸஸ் விமர்சனம் பலகை , மருந்துகள் கனடா ,